Back to Authors

Wetter, David A.

A5105938902 | I1330342723

Mayo Clinic

Citations 4

Lichen planus‐like drug eruption: A disproportionality analysis using FAERS database

Journal of the European Academy of Dermatology and Venereology | October 30, 2025 | Volume: 40 | Issue: 5 | Pages: No page available

10.1111/jdv.70140 | PMID 41165063

Post‐Marketing Safety of Bimekizumab in Psoriasis Patients: Pharmacovigilance Data From FDA Adverse Event Reporting System

International Journal of Dermatology | September 24, 2025 | Volume: 65 | Issue: 4 | Pages: 825-827

10.1111/ijd.70082 | PMID 40990361

Risk of adalimumab‐induced psoriasis in hidradenitis suppurativa versus other inflammatory diseases

Journal of the European Academy of Dermatology and Venereology | May 14, 2025 | Volume: 40 | Issue: 2 | Pages: No page available

10.1111/jdv.20743 | PMID 40365816

Secukinumab in bio‐experienced patients with moderate‐to‐severe hidradenitis suppurativa from a single center: an observational retrospective study

International Journal of Dermatology | November 20, 2024 | Volume: 64 | Issue: 5 | Pages: 949-951

10.1111/ijd.17583 | PMID 39564701